Abstract: The present invention is directed to compounds represented by the following structural formula, and pharmaceutically acceptable salts, solvates and hydrates thereof, R1 is a substituted or unsubstituted group selected from C1-C8 alkyl, aryl-C0-2-alkyl, heteroaryl-C0-2-alkyl, C3-C6 cycloalkylaryl-C0-2-alkyl or phenyl. W is O or S. R2 is H or a substituted or unsubstituted group selected from C1-C6 alkyl, C3-C6 cycloalkyl and heteroaryl. X is a C2-C5 alkylene linker wherein one carbon atom of the linker may be replaced with O, NH or S. Y is C, O, S, NH or a single bond. Furthermore, E is (CH2)nCOOH, wherein n is 0, 1, 2 or 3, or C(R3)(R4)A, wherein A is an acidic functional group such as carboxyl, carboxamide substituted or unsubstituted sulfonamide, or substituted or unsubstituted tetrazole. R3 is H, saturated or unsaturated C1-C5 alkyl, C1-C5 alkoxy. Additionally, R4 is H, halo, a substituted or unsubstituted group selected from C1-C5 alkyl, C1-C5 alkoxy, C3-C6 cycloalkyl, arylC0-C4alkyl and phenyl, or R3 and R4 are combined to form a C3-C4 cycloalkyl.
The present invention is directed to compounds represented by the following structural formula, and pharmaceutically acceptable salts, solvates and hydrates thereof, R1 is a substituted or unsubstituted group selected from C1-C8 alkyl, aryl-C0-2-alkyl, heteroaryl-C0-2-alkyl, C3-C6 cycloalkylaryl-C0-2-alkyl or phenyl. W is O or S. R2 is H or a substituted or unsubstituted group selected from C1-C6 alkyl, C3-C6 cycloalkyl and heteroaryl. X is a C2-C5 alkylene linker wherein one carbon atom of the linker may be replaced with O, NH or S. Y is C, O, S, NH or a single bond. Furthermore, E is (CH2)nCOOH, wherein n is 0, 1, 2 or 3, or C(R3)(R4)A, wherein A is an acidic functional group such as carboxyl, carboxamide substituted or unsubstituted sulfonamide, or substituted or unsubstituted tetrazole. R3 is H, saturated or unsaturated C1-C5 alkyl, C1-C5 alkoxy. Additionally, R4 is H, halo, a substituted or unsubstituted group selected from C1-C5 alkyl, C1-C5 alkoxy, C3-C6 cycloalkyl, arylC0-C4alkyl and phenyl, or R3 and R4 are combined to form a C3-C4 cycloalkyl.
| # | Name | Date |
|---|---|---|
| 1 | 2065-KOLNP-2007-ABSTRACT-1.pdf | 2018-09-20 |
| 1 | abstract-02065-kolnp-2007.jpg | 2011-10-07 |
| 2 | 02065-kolnp-2007-pct request form.pdf | 2011-10-07 |
| 2 | 2065-KOLNP-2007-CLAIMS-1.pdf | 2018-09-20 |
| 3 | 2065-KOLNP-2007-DESCRIPTION (COMPLETE)-1.pdf | 2018-09-20 |
| 3 | 02065-kolnp-2007-international search report.pdf | 2011-10-07 |
| 4 | 2065-KOLNP-2007-DESCRIPTION (COMPLETE)-2.pdf | 2018-09-20 |
| 4 | 02065-kolnp-2007-international publication.pdf | 2011-10-07 |
| 5 | 2065-KOLNP-2007-DESCRIPTION (COMPLETE)-3.pdf | 2018-09-20 |
| 5 | 02065-kolnp-2007-form 5.pdf | 2011-10-07 |
| 6 | 2065-KOLNP-2007-DESCRIPTION (COMPLETE)-4.pdf | 2018-09-20 |
| 6 | 02065-kolnp-2007-form 3.pdf | 2011-10-07 |
| 7 | 2065-KOLNP-2007-ABSTRACT.pdf | 2017-03-10 |
| 7 | 02065-kolnp-2007-form 3 1.1.pdf | 2011-10-07 |
| 8 | 2065-KOLNP-2007-CLAIMS.pdf | 2017-03-10 |
| 8 | 02065-kolnp-2007-form 2.pdf | 2011-10-07 |
| 9 | 02065-kolnp-2007-form 18.pdf | 2011-10-07 |
| 9 | 2065-KOLNP-2007-ABANDONED LETTER.pdf | 2017-01-19 |
| 10 | 02065-kolnp-2007-form 1.pdf | 2011-10-07 |
| 10 | 2065-KOLNP-2007-FIRST EXAMINATION REPORT.pdf | 2017-01-19 |
| 11 | 2065-KOLNP-2007-ABANDONED LETTER.pdf | 2016-10-05 |
| 12 | 02065-kolnp-2007-correspondence others.pdf | 2011-10-07 |
| 12 | 2065-KOLNP-2007_EXAMREPORT.pdf | 2016-06-30 |
| 13 | 02065-kolnp-2007-abstract.pdf | 2011-10-07 |
| 13 | 02065-kolnp-2007-correspondence others 1.1.pdf | 2011-10-07 |
| 14 | 02065-kolnp-2007-claims.pdf | 2011-10-07 |
| 15 | 02065-kolnp-2007-abstract.pdf | 2011-10-07 |
| 15 | 02065-kolnp-2007-correspondence others 1.1.pdf | 2011-10-07 |
| 16 | 02065-kolnp-2007-correspondence others.pdf | 2011-10-07 |
| 16 | 2065-KOLNP-2007_EXAMREPORT.pdf | 2016-06-30 |
| 17 | 2065-KOLNP-2007-ABANDONED LETTER.pdf | 2016-10-05 |
| 18 | 2065-KOLNP-2007-FIRST EXAMINATION REPORT.pdf | 2017-01-19 |
| 18 | 02065-kolnp-2007-form 1.pdf | 2011-10-07 |
| 19 | 2065-KOLNP-2007-ABANDONED LETTER.pdf | 2017-01-19 |
| 19 | 02065-kolnp-2007-form 18.pdf | 2011-10-07 |
| 20 | 02065-kolnp-2007-form 2.pdf | 2011-10-07 |
| 20 | 2065-KOLNP-2007-CLAIMS.pdf | 2017-03-10 |
| 21 | 02065-kolnp-2007-form 3 1.1.pdf | 2011-10-07 |
| 21 | 2065-KOLNP-2007-ABSTRACT.pdf | 2017-03-10 |
| 22 | 02065-kolnp-2007-form 3.pdf | 2011-10-07 |
| 22 | 2065-KOLNP-2007-DESCRIPTION (COMPLETE)-4.pdf | 2018-09-20 |
| 23 | 02065-kolnp-2007-form 5.pdf | 2011-10-07 |
| 23 | 2065-KOLNP-2007-DESCRIPTION (COMPLETE)-3.pdf | 2018-09-20 |
| 24 | 02065-kolnp-2007-international publication.pdf | 2011-10-07 |
| 24 | 2065-KOLNP-2007-DESCRIPTION (COMPLETE)-2.pdf | 2018-09-20 |
| 25 | 02065-kolnp-2007-international search report.pdf | 2011-10-07 |
| 25 | 2065-KOLNP-2007-DESCRIPTION (COMPLETE)-1.pdf | 2018-09-20 |
| 26 | 2065-KOLNP-2007-CLAIMS-1.pdf | 2018-09-20 |
| 26 | 02065-kolnp-2007-pct request form.pdf | 2011-10-07 |
| 27 | abstract-02065-kolnp-2007.jpg | 2011-10-07 |
| 27 | 2065-KOLNP-2007-ABSTRACT-1.pdf | 2018-09-20 |